Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 4890 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d568-ad7c-74f8-becb-5baabac1ec46

adms:identifier	mi-legislature-measure 2023-2024/HB/4890
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Curtis S VanderWall
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4890 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4890 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4890
schema:legislationChanges	MCL 125.2009
schema:legislationIdentifier	HB 4890
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; insulin production program; establish. Amends sec. 9 of 1984 PA 270 (MCL 125.2009 ) & adds ch. 8F.en
schema:sponsor	Kathy Schmaltz Sharon MacDonell Brian BeGole Gregory Alexander Curtis S VanderWall John R. Roth Ken Borton
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4890
skos:prefLabel	HB 4890 (2023-2024)en
status	reported
status date	2024-05-22xsd:date